Morphine Study in Obesity and Sleep Apnea Patients

We are investigating how obesity and obstructive sleep apnea influence the effects of morphine for pain relief. This research aims to improve pain management for patients, especially those having bariatric surgery.

>2 years Efficacy phase (II)No Placebo Cost Reimbursement Standard Medicines InjectionEndocrinologyInternal MedicineOrthopedics and TraumatologyOtolaryngologyPsychiatry

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Lidocaine Hydrochloride

Lidocaine hydrochloride is a substance that numbs a specific area to relieve pain during minor procedures and dental treatments.

Morphine Hydrochloride

Morphine hydrochloride is a substance that relieves severe pain by decreasing the body's perception of pain.

Naloxone Hydrochloride

Naloxone hydrochloride is a substance that quickly reverses opioid effects to restore breathing in overdose emergencies.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Sydvestjysk Sygehus

Department of anaesthesia and intensive care

Esbjerg, Denmark

Sponsor: Sydvestjysk Sygehus

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.